海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
6814件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Does Zumba Improve Cognition in Healthy APOE e4 Carriers and Noncarriers
- Cognitive Impairment
- United States
- 2009-11-11
Not Recruiting
- Effect of L-92 for ECRS
- Eosinophilic rhinosinusitis
- Japan
- 2019-02-21
Not Recruiting
- Study Evaluating the Efficacy and Safety of Bapineuzumab in Alzheimer Disease Patients Who Are Apolipoprotein E e4 Carriers
- Alzheimer Disease MedDRA version: 14.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Chile, Croatia, Denmark, Finland, France, Germany, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Poland, Portugal, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States
- 2008-02-22
Not Recruiting
- Ensayo de fase III, multicéntrico, aleatorizado, en doble ciego, controlado con placebo y de grupos paralelos, sobre la eficacia y la seguridad del bapineuzumab (AAB-001, ELN115727) en pacientes con enfermedad de Alzheimer de grado leve a moderado que no son portadores de la apolipoproteína E (ApoE) e4 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E e4 Non-carriers
- Enfermedad de Alzheimer Alzheimer Disease MedDRA version: 9.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type ;Enfermedad de Alzheimer Alzheimer Disease MedDRA version: 9.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type
- Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Portugal, Slovakia, Spain, Sweden, United Kingdom
- 2008-02-25
Not recruiting
- Does APOE-e4 Predict Delirium and Cognitive Dysfunction After Surgery?
- Delirium;Postoperative Cognitive Dysfunction
- Canada
- 2009-05-29
Not Recruiting
- UKALL XI (92) - Acute lymphoblastic leukaemia trial
- Leukaemia Cancer Acute lymphoblastic leukaemia
- United Kingdom
- 2000-10-25
Not recruiting
- The Impact of Lorazepam on Cognition in APOE e4 Carriers
- Alzheimer's Disease
- United States
- 2007-12-21
Recruiting
- Mind the Gap (AIR-B3)
- Autism Spectrum Disorder
- United States
- 2018-10-12
Not Recruiting
- A 54-week, double-blind, randomized, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone (extended release tablets) as adjunctive therapy to donepezil on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease (REFLECT-2) - REFLECT-2
- Alzheimers Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease ;Alzheimers Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease
- Austria, Czech Republic, Germany, Greece, Hungary, Italy, Portugal, Spain
- 2006-07-20
Authorised
- A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1)
- Mild to Moderate Alzheimer's Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease
- Austria, Bulgaria, Estonia, Germany, Greece, Hungary, United Kingdom
- 2006-11-23